Deutsche Bank Says Buy the Weakness in This Big Dividend Telecom Stock
Every once in a while, investors get the kind of gift that pays off in an outstanding way because others investors shoot first and ask questions later.
All Work
Lee Jackson
4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts
A new report from Wedbush focuses on upcoming catalysts for biotech stocks in the firm's coverage universe. These four have monster potential upside to the posted price targets.
Analyst Picks 2 Top Solar Stocks to Buy Ahead of Earnings
In a new Baird research report, while the analysts are positive on alternative energy as a whole, they are very selective on the stocks they like.
With Oil Down Over 20% in a Month, 4 Stocks to Buy Yielding 4% or More
With major production cuts and rig counts well below two years ago, now may be a good time to nibble at some of the top oil stocks that have been hammered over the past…
4 Dividend Stocks That Would Thrive Under a Donald Trump Presidency
A top-notch Jefferies economist believes the rise in populism is the most important issue the markets face today, and that the biggest impact from a Trump win would be a weaker U.S. dollar.
Merrill Lynch Has 4 Telecom Yield at a Reasonable Price Stocks to Buy
The general consensus is that telecom is overbought and a crowded trade, but Merrill Lynch thinks that from a yield perspective it still makes sense for investors looking for dividends.
RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains
Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there was little to no mention of drug pricing.
2 Tech Giants Highlight Jefferies Growth Stocks to Buy This Week
This week the analysts at Jefferies are focusing their top growth stock picks on some very large and liquid stocks, and two of them are technology leaders that posted outstanding second-quarter earnings.
Huge Blue Chip Tech Trade Highlights Insider Selling: Microsoft, Diamond Resorts, PulteGroup, Tupperware, JB Hunt and More
The tsunami of insider selling that was kicked off when the market broke through to all-time highs slowed down a little last week, but there were still some pretty big waves.
Massive Netflix Purchase Highlights Insider Buying: General Electric, Delta Airlines, Mattress Firm, Bank of New York Mellon and More
Some backup in the markets and some steep sell-offs in individual companies sure did open the door for insider buyers this past week.
Wedbush Has 3 Stocks to Buy With 70% to 140% Upside Potential
These three biotech companies not only have data that could prove to be huge, but they have been absolutely hammered over the last year and are offering aggressive accounts the best entry points in…
Merrill Lynch Has 4 Top Dividend Stocks Called Huge Bargains Now
These four top stocks that pay at least a 3% dividend also offer investors outstanding entry points at current levels.
Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio
Despite the fact that energy has tumbled 20% from the highs posted in June, Jefferies remains bullish on the natural gas arena, and with good reason.
Merrill Lynch Bullish on 3 Blue Chip Dividend Leaders for Rest of 2016
The biggest companies are often the safest to buy, and with the market still right at all-time highs, these liquid, large cap leaders make good sense now.
SunTrust Says Buy These 3 High-Profile Stocks Hit Hard After Earnings
Sometimes the best entry point for a stock you have been waiting to buy is when it either has a poor earnings quarter or gives guidance that disappoints.
4 Surprising Quality Growth Stocks That Pay at Least a 5% Dividend
At 24/7 Wall St. we are constantly on the lookout for stocks that pay good dividends, are not horribly overbought and are rated reasonably high by some of the top firms we cover.
Why Merrill Lynch Sees Enterprise Products and Top MLPs Rising Higher After Earnings
Fortunately for investors, some of the top stocks in the energy and master limited partnership (MLP) space have backed up and are offering a very solid entry point.
JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now
A new JPMorgan research report says it time to buy the health care sector and sell consumer staples, which have run hard this year.
Why Deutsche Bank Still Loves These 3 Utilities Stocks
Deutsche Bank also says that utility stocks that provide solid single-digit growth and yields between 3% and 4% remain attractive.
Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016
SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new products, attractive dividends and solid performance as positives.